What is the treatment for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cellulitis

First-Line Antibiotic Therapy

Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis, with a 96% success rate, and MRSA coverage is NOT routinely necessary. 1

Recommended Oral Agents

  • Cephalexin 500 mg orally every 6 hours (four times daily) for 5 days is the preferred first-line agent for typical nonpurulent cellulitis 1, 2
  • Dicloxacillin 250-500 mg every 6 hours provides excellent streptococcal and MSSA coverage 1, 3
  • Amoxicillin, amoxicillin-clavulanate, or penicillin are equally appropriate alternatives 1
  • Clindamycin 300-450 mg orally every 6 hours covers both streptococci and MRSA if local resistance is <10% 1

Recommended IV Agents for Hospitalized Patients

  • Cefazolin 1-2 g IV every 8 hours is the preferred IV beta-lactam for hospitalized patients requiring parenteral therapy 1
  • Nafcillin 2 g IV every 6 hours or oxacillin 2 g IV every 6 hours are alternatives 1

Treatment Duration

Treat for exactly 5 days if clinical improvement has occurred; extend only if symptoms have not improved within this timeframe. 1, 4

  • Five-day courses are as effective as 10-day courses for uncomplicated cellulitis based on high-quality randomized controlled trial evidence 1, 4
  • Clinical resolution at 14 days with no relapse by 28 days occurred in 98% of patients receiving 5 days versus 98% receiving 10 days 4
  • Traditional 7-14 day courses are no longer necessary for uncomplicated cases 1

Common pitfall: Do not reflexively extend treatment to 7-10 days based on residual erythema alone, as some inflammation persists even after bacterial eradication 1

When to Add MRSA Coverage

Add MRSA-active antibiotics ONLY when specific risk factors are present: 1

  • Penetrating trauma or injection drug use 1
  • Purulent drainage or exudate 1
  • Evidence of MRSA infection elsewhere or known nasal MRSA colonization 1
  • Systemic inflammatory response syndrome (SIRS): fever >38°C, tachycardia >90 bpm, hypotension, or altered mental status 1
  • Failure to respond to beta-lactam therapy after 48-72 hours 1

MRSA Coverage Options

When MRSA coverage is indicated:

  • Clindamycin 300-450 mg orally every 6 hours provides single-agent coverage for both streptococci and MRSA (use only if local resistance <10%) 1
  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin, amoxicillin, or penicillin) 1
  • Doxycycline 100 mg orally twice daily PLUS a beta-lactam 1

Critical caveat: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis, as their activity against beta-hemolytic streptococci is unreliable 1

Severe Cellulitis Requiring Hospitalization

Indications for Hospitalization

Admit patients with any of the following: 1

  • SIRS criteria (fever, tachycardia, hypotension, altered mental status) 1
  • Severe immunocompromise or neutropenia 1
  • Concern for deeper or necrotizing infection 1
  • Failure of outpatient treatment after 24-48 hours 1

IV Antibiotic Regimens for Severe Infections

For patients with signs of systemic toxicity, rapid progression, or suspected necrotizing fasciitis, mandatory broad-spectrum combination therapy is required: 1

  • Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
  • Alternative: Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 1
  • Alternative: Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1
  • Alternative: Vancomycin PLUS ceftriaxone 2 g IV daily and metronidazole 500 mg IV every 8 hours 1

Treatment duration for severe cellulitis is 7-10 days, not the standard 5 days, with reassessment at 5 days. 1

Transition to Oral Therapy

  • Patients can transition to oral antibiotics once clinical improvement is demonstrated, typically after a minimum of 4 days of IV treatment 1
  • Oral options include cephalexin, dicloxacillin, or clindamycin 1

Essential Adjunctive Measures

Elevation of the affected extremity is critical and often neglected—it hastens improvement by promoting gravity drainage of edema and inflammatory substances. 1

  • Elevate the limb above heart level for at least 30 minutes three times daily 1
  • Examine interdigital toe spaces carefully for tinea pedis, fissuring, scaling, or maceration 1
  • Treat predisposing conditions including venous insufficiency, lymphedema, eczema, chronic edema, and obesity 1
  • Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1

Critical caveat: Avoid systemic corticosteroids in diabetic patients despite potential benefit in non-diabetics 1

Special Populations

Diabetic Foot Cellulitis

Diabetic patients with foot cellulitis require broader coverage and longer duration: 1

  • Mild infections: dicloxacillin, clindamycin, cephalexin, trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, or levofloxacin 1
  • Moderate infections: amoxicillin-clavulanate, levofloxacin, ceftriaxone, ampicillin-sulbactam, or ertapenem 1
  • Severe infections: piperacillin-tazobactam, imipenem-cilastatin, or vancomycin plus ceftazidime with or without metronidazole 1
  • Median treatment duration extends beyond the standard 5-day course 1

Penicillin/Cephalosporin Allergy

  • Clindamycin 300-450 mg orally every 6 hours is the optimal choice for patients allergic to both penicillins and cephalosporins 1
  • Provides single-agent coverage for both streptococci and MRSA without requiring combination therapy 1
  • Use only if local MRSA clindamycin resistance rates are <10% 1

Pediatric Cellulitis

  • Cephalexin 25 mg/kg/day in four divided doses for typical nonpurulent cellulitis 1
  • For hospitalized children: vancomycin 15 mg/kg IV every 6 hours as first-line therapy 1
  • Alternative: clindamycin 10-13 mg/kg/dose IV every 6-8 hours if stable, no bacteremia, and local resistance <10% 1
  • Never use doxycycline in children under 8 years of age due to tooth discoloration and bone growth effects 1

Prevention of Recurrent Cellulitis

Annual recurrence rates are 8-20% in patients with previous leg cellulitis. 1

  • Treat tinea pedis and interdigital toe web abnormalities 1
  • Manage venous insufficiency with compression stockings once acute infection resolves 1
  • Reduce lymphedema 1
  • Keep skin well hydrated with emollients 1

For patients with 3-4 episodes per year despite treating predisposing factors, consider prophylactic antibiotics: 1

  • Oral penicillin V 250 mg twice daily for 4-52 weeks 1
  • Oral erythromycin 250 mg twice daily 1
  • Intramuscular benzathine penicillin every 2-4 weeks 1

Monitoring and Treatment Failure

  • Reassess within 24-48 hours for outpatients to ensure clinical improvement 1
  • If no improvement with appropriate first-line antibiotics, consider resistant organisms (especially MRSA), cellulitis mimickers (DVT, necrotizing fasciitis), or underlying complications 1, 5
  • Blood cultures are positive in only 5% of cases and are unnecessary for typical cellulitis 1
  • Obtain blood cultures only in patients with severe systemic features, malignancy, neutropenia, or unusual predisposing factors 1

Warning signs requiring immediate surgical consultation: 1

  • Severe pain out of proportion to examination findings 1
  • Skin anesthesia 1
  • Rapid progression or "wooden-hard" subcutaneous tissues 1
  • Gas in tissue or bullous changes 1
  • Systemic toxicity with hypotension or altered mental status 1

References

Guideline

Management of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.